All News

Patient Access & Engagement

Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
13 September 2023
Phacilitate Announces Lifetime Achievement Award Winner for 2024, and Opens Entries for the Second Advanced Therapies Awards 
Following a show-stopping and emotional
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
6 September 2023
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
Beam Therapeutics Announced First Patient
uniQure Announces FDA Clearance of INDA for Epilepsy Gene Therapy
5 September 2023
uniQure Announces FDA Clearance of INDA for Epilepsy Gene Therapy
uniQure Announces FDA Clearance of
First Person in Europe Commercially Treated with BioMarin’s ROCTAVIAN® for Severe Hemophilia A
31 August 2023
First Person in Europe Commercially Treated with BioMarin’s ROCTAVIAN® for Severe Hemophilia A
BioMarin's ROCTAVIAN gene therapy has
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

Unlocking the Future of Advanced Therapies: A European Event Full of Promise and Inspiration
21 July 2023
Unlocking the Future of Advanced Therapies: A European Event Full of Promise and Inspiration
As we enter the 7-week
Celebrating a Lifetime of Life-Changing Achievements
21 July 2023
Celebrating a Lifetime of Life-Changing Achievements
As entries for the 2024
Cell and Gene Therapy Summit – Conversations Dedicated to Manufacturing Challenges, Investment Opportunities and Regulatory Harmonization
15 June 2023
Cell and Gene Therapy Summit – Conversations Dedicated to Manufacturing Challenges, Investment Opportunities and Regulatory Harmonization
The Phacilitate Editorial team was
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
5 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map